chunk_size,top_k,top_k_rerank,query,answer_without_citation,qa_similarity,citation_answer_max_similarity,citation_answer_min_similarity
500,20,5,What is known about APOE and Alzheimer’s disease?,"The provided citations discuss the role of APOE in Alzheimer's disease, highlighting its association with the disease and its impact on the genetic landscape.",0.8656308650970459,0.8709431886672974,0.6273064613342285
500,20,5,How do TREM2 variants influence the risk of Alzheimer’s disease?,"The provided citations highlight the role of TREM2 variants in the risk of Alzheimer's disease. A comprehensive study identified five new genome-wide associations for load and showed that genetic pleiotropy or co-morbidity of these traits with pathology of load. The study also highlights the enrichment of rare variants in pathways associated with Alzheimer's disease, indicating that additional rare variants remain to be identified, and larger",0.8714812397956848,0.8567572236061096,0.6264946460723877
500,20,5,What evidence links ABCA7 to Alzheimer’s pathology?,"The provided citations discuss the role of the ABCA7 gene in Alzheimer's disease pathology. Specifically, they highlight its expression in Alzheimer's disease versus control brains, evaluation of transcriptomic expression in Alzheimer's disease tissues, and gene cluster pathway analyses. The study also identifies rare abca7 variants in two German families with Alzheimer's disease and provides evidence linking abca7 expression to increased cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer's disease.",0.818911075592041,0.8400421738624573,0.513437032699585
500,20,5,Are there genetic loci associated with early-onset Alzheimer’s disease?,"A genome-wide association study (GWAS) has identified several genetic loci associated with the risk of late-onset Alzheimer's disease. These loci, including abca7, ms4a6ams4a4e, epha1, cd33, and cd2ap, have been found to be associated with the disease. Additionally, the hla-dqa10301hla-dqb10302 haplotype has also been found to be not associated with Alzheimer's disease. These findings suggest that multiple genetic loci may contribute to the development of Alzheimer's disease, highlighting the complexity of the disease and the need for further research to better understand its pathophysiology.",0.8292132019996643,0.8365896940231323,0.6687785983085632
500,20,5,Which biological pathways are most commonly implicated in Alzheimer’s according to recent genomic studies?,"Recent genomic studies have identified several biological pathways most commonly implicated in Alzheimer's disease (AD). These pathways include the neuronal and synaptic function pathways, as well as cell types such as monocytes, macrophages, and brain-derived neurotrophic factor (BDNF). The study by Chung et al. (2019) highlights the role of genes like cr1, abca7, bin1, spi1, ms4a2, ms4a6a, and ms4a4a in AD, with these genes being expressed in brain regions of AD patients. The findings suggest that these genes are involved in neuronal and synaptic function, as well as in the development and progression of AD.",0.6324502229690552,0.7295868396759033,0.49455058574676514
500,20,5,How does CLU (Clusterin) contribute to Alzheimer’s risk or pathology?,"The provided citations discuss the role of CLU (Clusterin) in Alzheimer's disease risk and pathology. CLU is identified as a genetic susceptibility locus associated with the disease, and its expression is found to be elevated in Alzheimer's disease versus control brains. Additionally, transcriptomic expression in Alzheimer's disease versus control tissues and various gene clusterpathway analyses support the role of CLU in Alzheimer's disease.",0.9148598313331604,0.7300389409065247,0.5443644523620605
500,20,5,What role does inflammation play in the genetic risk architecture of Alzheimer’s?,"Inflammation plays a significant role in the genetic risk architecture of Alzheimer's disease. The study by Karlsson et al. (2018) identifies 9 novel loci and functional pathways for Alzheimer's disease risk, while the research by Kuma et al. (2018) reveals interactions with apolipoprotein genes that contribute to the development of late-onset Alzheimer's disease. These findings highlight the importance of inflammation in the pathogenesis of Alzheimer's disease.",0.8055596947669983,0.787632942199707,0.5705601572990417
500,20,5,Which rare variants have been identified that affect amyloid processing in Alzheimer’s?,"The citations provided discuss the identification of rare variants associated with amyloid processing in Alzheimer's disease. These variants, particularly those involved in the processing of amyloid beta peptide, are not only associated with early-onset autosomal dominant alzheimer's disease but also with load, which is a genetic factor. The studies identified 19 genome-wide significant common variant signals, including clu and picalm, which are associated with alzheimers disease. Additionally, bis, jc, and verheijen's studies highlight the potential of these rare variants in understanding disease mechanisms and potential drug targets.",0.8158606886863708,0.7948712110519409,0.6029213666915894
500,20,5,How do lipid metabolism genes contribute to Alzheimer’s disease susceptibility?,"The provided citations discuss the role of lipid metabolism genes in Alzheimer's disease susceptibility. Specifically, they highlight the significant correlation between common and rare pathway gene results and the prevalence of Alzheimer's disease. The study also emphasizes the importance of understanding the genetic architecture of gene expression in lipid metabolism, which is a key factor in the development of Alzheimer's disease.",0.9138211011886597,0.7200708389282227,0.6184056401252747
500,20,5,What genomic findings support the involvement of microglial function in Alzheimer’s disease?,"The provided citations support the involvement of microglial function in Alzheimer's disease by identifying specific genes and gene sets that are enriched for microglial-related traits in aged human microglia. These genes include those in the prefrontal cortex, cerebellum, visual cortex, and a set of 1,054 genes preferentially expressed in aged microglial cells. Additionally, the list of genes annotated with brain RNA-seq data shows that 80 of these genes are expressed in at least one type of brain cell, further supporting the role of microglial function in Alzheimer's disease.",0.7621346712112427,0.8905469179153442,0.5594117641448975
500,50,5,What is known about APOE and Alzheimer’s disease?,"The provided citations discuss the relationship between APOE and Alzheimer's disease, highlighting that APOE is the major genetic risk factor for sporadic late-onset Alzheimer's disease. The study by Koran et al. (2017) found that apolipoprotein E (APOE) is the strongest genetic risk factor for Alzheimer's disease, with a stronger association among females. Additionally, the research by Barnes et al. (2006) and Verghese et al. (2013) suggest that APOE influences amyloid-beta (Aβ) clearance despite minimal Aβ-Aβ association in physiological conditions.",0.7310166954994202,0.8527482748031616,0.49757421016693115
500,50,5,How do TREM2 variants influence the risk of Alzheimer’s disease?,"The provided citations discuss the genetic and environmental factors that influence the risk of Alzheimer's disease. The study by Jonsson et al. (2013) identified five new genome-wide associations for load and showed that genetic pleiotropy or co-morbidity of these traits with pathology of load can reveal rare disease risk variants. The study by Bellenguez et al. (2017) identified five new genome-wide associations for load and showed that high-quality imputation panels can reveal rare disease risk variants. The findings from the 2016 study by Kunkle et al. (2011) and the 2017 study by Karran et al. (2017) further support the identification of rare variants in trem2, sorl1, and abca7 in 1779 cases and 1273 controls.",0.6736860275268555,0.9140143990516663,0.42028969526290894
500,50,5,What evidence links ABCA7 to Alzheimer’s pathology?,"The provided citations discuss the role of the ABCA7 gene in Alzheimer's disease pathology. The ABCA7 gene is associated with Alzheimer's disease risk, as it is a key gene in the pathogenesis of the disease. The studies mentioned in the citations, such as those by Kunkle et al., de Roeck et al., and Chapuis et al., provide evidence that deletions or mutations in the ABCA7 gene increase the risk of developing Alzheimer's disease. These findings support the notion that ABCA7 is a significant factor in the development of Alzheimer's disease.",0.8538484573364258,0.8402305841445923,0.4162456691265106
500,50,5,Are there genetic loci associated with early-onset Alzheimer’s disease?,"The provided citations discuss the genetic factors associated with early-onset Alzheimer's disease, including the identification of new risk loci and the role of environmental factors.",0.8317757248878479,0.8105672001838684,0.6293236613273621
500,50,5,Which biological pathways are most commonly implicated in Alzheimer’s according to recent genomic studies?,"Recent genomic studies have identified several biological pathways most commonly implicated in Alzheimer's disease (AD). These pathways include the tau protein, lipid, immunity, and a pathways, as well as genes and pathways related to neuronal or synaptic function. Genetic factors affecting early AD changes are also identified, and genetic factors affecting early changes for AD via expression are proposed.",0.7584502696990967,0.7920176386833191,0.5518186092376709
500,50,5,How does CLU (Clusterin) contribute to Alzheimer’s risk or pathology?,"CLU, a gene associated with Alzheimer's disease, plays a role in the development of the disease by interacting with other genetic variants and contributing to the pathogenesis of the condition. The studies mentioned in the citations, such as the meta-analysis, genome-wide association study, and clusterin studies, highlight the importance of CLU in Alzheimer's disease risk and pathology.",0.8693940043449402,0.7752103805541992,0.47129756212234497
500,50,5,What role does inflammation play in the genetic risk architecture of Alzheimer’s?,"Inflammation plays a significant role in the genetic risk architecture of Alzheimer's disease (AD). The article highlights that AD is the most common form of dementia, and its genetic risk factors currently account for only a small portion of the disorder's overall heritability. The genetic meta-analysis identified nine novel risk loci and functional pathways, emphasizing the importance of inflammation in AD.",0.8699847459793091,0.8180328607559204,0.5770891904830933
500,50,5,Which rare variants have been identified that affect amyloid processing in Alzheimer’s?,"A comprehensive study of the genetic impact of rare variants in sorl1 in Alzheimer's disease reveals that additional rare variants remain to be identified, and larger samples and better imputation panels will facilitate their discovery. While these rare variants may not contribute substantially to the predictive value of genetic findings, they will enhance the understanding of disease mechanisms and potential drug targets.",0.6751700639724731,0.8506260514259338,0.5097890496253967
500,50,5,How do lipid metabolism genes contribute to Alzheimer’s disease susceptibility?,"The provided citations discuss the role of lipid metabolism genes in Alzheimer's disease susceptibility. Specifically, they highlight that certain genes, such as the common and rare pathway gene results p 1.32 107, are enriched for rare variants, suggesting that risk genes for Alzheimer's disease are influenced by these pathways. Additionally, the study identifies a correlation between common and rare pathway gene results, indicating that susceptibility to Alzheimer's disease is influenced by both common and rare genetic variants. The research also emphasizes the importance of studying early-onset families to develop therapies for the more common late-onset form of the disease.",0.8453103303909302,0.7978880405426025,0.5616762638092041
500,50,5,What genomic findings support the involvement of microglial function in Alzheimer’s disease?,"Microglial function plays a crucial role in Alzheimer's disease, as identified through genomic studies. These studies, including those from the National Institutes of Health, have found that rare coding variants in plcg2, abi3, and trem2, as well as whole-genome sequencing of the Icelandic population, implicate microglial-mediated innate immunity in the development of Alzheimer's disease. This highlights the importance of understanding microglial function in the context of Alzheimer's disease.",0.7935453057289124,0.8918662071228027,0.5353790521621704
500,50,10,What is known about APOE and Alzheimer’s disease?,"The provided citations discuss the genetic factors associated with Alzheimer's disease (AD), including the apolipoprotein E (APOE) gene, which is the strongest genetic risk factor for AD. The study by Teslovich et al. (2016) confirms that APOE is the major gene influencing AD survival in long-lived individuals. Additionally, the study by Nixon et al. (2017) explores the inverse relationship between cancer and AD, suggesting that the polygenic architecture of AD may also be heterogeneous across age.",0.6838328838348389,0.8558683395385742,0.5642327070236206
500,50,10,How do TREM2 variants influence the risk of Alzheimer’s disease?,"The provided citations discuss the genetic impact of rare variants in Alzheimer's disease, including trem2, sorl1, and abca7. These variants are associated with the risk of Alzheimer's disease, and the study identified five genome-wide significant loci.",0.8052959442138672,0.8825250864028931,0.46542543172836304
500,50,10,What evidence links ABCA7 to Alzheimer’s pathology?,"CRISPR-Cas9 gene editing works by using a guide RNA to direct the Cas9 enzyme to specific genomic sequences, where it creates targeted double-strand breaks in DNA. This process is influenced by various factors, including the expression of the ABCA7 gene, which is associated with Alzheimer's pathology. The study by Kunkle et al. (2015) identified rare variants in the ABCA7 gene that confer a risk of Alzheimer's disease, while the study by de Roque et al. (2011) found that common variants at this gene are associated with the risk of Alzheimer's disease.",0.6743110418319702,0.7416297793388367,0.3954680860042572
500,50,10,Are there genetic loci associated with early-onset Alzheimer’s disease?,"Genetic loci associated with early-onset Alzheimer's disease have been identified through genome-wide association studies. The study identified 11 new susceptibility loci and functional pathways influencing Alzheimer's disease risk. These loci have potential co-morbid or pleiotropic associations with other traits, suggesting that understanding the genetic architecture of Alzheimer's disease could provide valuable insights into the disease's pathogenesis.",0.8651771545410156,0.8930716514587402,0.5788352489471436
500,50,10,Which biological pathways are most commonly implicated in Alzheimer’s according to recent genomic studies?,"Recent genomic studies have identified several biological pathways implicated in Alzheimer's disease (AD), including the tau, lipid, immunity, and a pathways. These pathways are enriched for rare variants, and the prioritized genes in AD are expressed in brain cell types such as monocytes, macrophages, and neurons. The study also highlights the role of these genes in early-onset and more common late-onset AD, suggesting that therapies developed from studying early-onset families could also be applicable to the more common late-onset form of the disease.",0.6675840020179749,0.7010246515274048,0.5054238438606262
500,50,10,How does CLU (Clusterin) contribute to Alzheimer’s risk or pathology?,"The provided citations support the findings that clusterin (CLU) is associated with Alzheimer's disease risk and pathology. CLU is a gene that is part of the clusterin isoform, which plays a role in neuronal differentiation and function. The meta-analysis, genome-wide association study, and other studies identified CLU and its variant picalm as risk loci for Alzheimer's disease. Additionally, the gene clusterpathway analyses and gene cluster pathway analyses further support the association of CLU with pathological diagnosis of Alzheimer's disease.",0.8706555366516113,0.7718492746353149,0.4563446342945099
500,50,10,What role does inflammation play in the genetic risk architecture of Alzheimer’s?,"Inflammation plays a significant role in the genetic risk architecture of Alzheimer's disease (AD). The article ""Genetic Meta-Analysis of Diagnosed Alzheimer's Disease Identifies New Risk Loci and Implicates a, tau, immunity and lipid processing"" (nihms-1021255) highlights the identification of nine novel risk loci and functional pathways associated with AD risk. Additionally, ""Alzheimers Disease Genetic, C., Cohorts for, H., Aging Research in Genomic, E., Moebus S, Mecocci P, Del Zompo M, Maier W, Hampel H, Pilotto A, Bullido M, Panza F, Caffarra P, Nacmias B, Gilbert Jr, Mayhaus M, Lannefelt L, Hakonarson H, Pichler S, Carrasquillo M, Ingelsson M, Beekly D, Alvarez V, Zou F, Valladares O, Younkin S, Coto E, Hamilton-Nelson K, Gu W, Razquin C, Pastor P, Mateo I, Owen M"" (nihms-1051989) discusses the potential role of endoplasmic reticulum stress in human pathology and its potential involvement in AD.",0.7835464477539062,0.7987611293792725,0.5772801041603088
500,50,10,Which rare variants have been identified that affect amyloid processing in Alzheimer’s?,"The provided citations highlight the identification of rare variants in Alzheimer's disease that affect amyloid processing. These variants, such as p 1.32 107, p 0.05, and p 0.05, are enriched for genetic correlations with factors like family history of dementia and education. Additionally, the study identified 50 common and 2 late-onset genes associated with the amyloidogenic pathway, contributing to our understanding of the disease's molecular mechanisms.",0.8561000823974609,0.7925986051559448,0.5934679508209229
500,50,10,How do lipid metabolism genes contribute to Alzheimer’s disease susceptibility?,"The provided citations discuss the role of lipid metabolism genes in Alzheimer's disease susceptibility. The study found that certain metabolic traits, such as fasting glucose, fasting insulin, and high-density lipoprotein (HDL), are associated with Alzheimer's disease risk. Additionally, the genetic architecture of cardiovascular-associated genes that increase the risk for Alzheimer's disease was identified, highlighting the importance of cardiovascular biology in the development of clinical Alzheimer's disease.",0.8157335519790649,0.8014271259307861,0.5483919978141785
500,50,10,What genomic findings support the involvement of microglial function in Alzheimer’s disease?,"Microglial function plays a crucial role in Alzheimer's disease, as identified through genomic studies. These studies have uncovered rare coding variants in genes such as plcg2, abi3, and trem2, which are associated with microglial-mediated innate immunity. Additionally, large-scale whole-genome sequencing of the Icelandic population has revealed new loci and functional pathways influencing Alzheimer's disease risk. These findings highlight the importance of microglial function in the pathogenesis of Alzheimer's disease.",0.761419951915741,0.8837525844573975,0.5168060064315796
1000,20,5,What is known about APOE and Alzheimer’s disease?,"The provided citations discuss the relationship between APOE and Alzheimer's disease, highlighting the role of the apolipoprotein E (APOE) gene in the development of the disease. The study on APOE promoter polymorphisms and Alzheimer's disease reveals that certain polymorphisms in the apolipoprotein E (APOE) gene are associated with an increased risk of developing Alzheimer's disease. These findings suggest that the apolipoprotein E (APOE) gene may play a role in the pathogenesis of Alzheimer's disease, and further research is needed to understand the mechanisms underlying this association.",0.7290224432945251,0.8393166661262512,0.5042967200279236
1000,20,5,How do TREM2 variants influence the risk of Alzheimer’s disease?,"The provided citations discuss the effects of vitamin D deficiency and Alzheimer's disease risk, but they do not contain information on how TREM2 variants influence the risk of Alzheimer's disease.",0.8482524156570435,0.7013189792633057,0.4694923758506775
1000,20,5,What evidence links ABCA7 to Alzheimer’s pathology?,"The provided citations link to several studies that explore the genetic and epigenetic factors associated with Alzheimer's disease (AD). These studies discuss the role of specific genes, including abca7, sorl1, and abca7 variants, in AD pathology. The studies also highlight the impact of these genetic variants on AD risk and neuroimaging findings.",0.7398553490638733,0.7539097666740417,0.5203151702880859
1000,20,5,Are there genetic loci associated with early-onset Alzheimer’s disease?,"The provided citations discuss the genetic loci associated with early-onset Alzheimer's disease, including the identification of new susceptibility loci such as ad, tau, immunity, and lipid processing. Additionally, the meta-analysis identifies 29 risk loci and functional pathways that influence the risk of late-onset Alzheimer's disease.",0.8131009340286255,0.8573334217071533,0.6312641501426697
1000,20,5,Which biological pathways are most commonly implicated in Alzheimer’s according to recent genomic studies?,"Recent genomic studies have implicated several biological pathways in Alzheimer's disease, including the tau protein, which is overexpressed in adolescent and young adult brain tissues. Additionally, environmental factors such as erythropoietin and microarray analysis of the astrocyte transcriptome have been identified as risk factors for the disease.",0.6457856893539429,0.6983629465103149,0.5090864896774292
1000,20,5,How does CLU (Clusterin) contribute to Alzheimer’s risk or pathology?,"The provided citations discuss the role of clusterin in Alzheimer's disease risk and pathology. Clusterin is identified as a variant associated with the disease, and its expression is linked to cognitive decline, cerebrospinal fluid biomarkers, and neuroimaging findings.",0.8033748865127563,0.8064613342285156,0.43118444085121155
1000,20,5,What role does inflammation play in the genetic risk architecture of Alzheimer’s?,"The provided citations support the idea that inflammation plays a role in the genetic risk architecture of Alzheimer's disease (AD). The meta-analysis of 74,046 individuals identified 11 new susceptibility loci for AD, and genetic, environmental, and clinical evidence suggests that apolipoprotein E (APOE) is a major gene influencing survival in long-lived individuals. Additionally, late-onset AD genetic susceptibility risks have been evaluated in a Canadian population.",0.7818154096603394,0.8179787397384644,0.5768402218818665
1000,20,5,Which rare variants have been identified that affect amyloid processing in Alzheimer’s?,"The provided citations discuss the identification of rare variants in Alzheimer's disease, including those that affect amyloid processing. These variants, such as p 1.32 107, p 1.32 107, and p 1.32 107, are associated with increased risk of load and are not only linked to early-onset autosomal dominant alzheimers disease but also to the more common late-onset form. The study also highlights the importance of converging evidence from existing and new analyses in prioritizing risk genes and suggests that therapies developed by studying early-onset families could also be applicable to the more common late-onset form of the disease.",0.7868393063545227,0.7557869553565979,0.6029987335205078
1000,20,5,How do lipid metabolism genes contribute to Alzheimer’s disease susceptibility?,"The provided citations discuss the genetic and metabolic factors that contribute to Alzheimer's disease susceptibility. Specifically, they highlight the role of lipid metabolism genes in Alzheimer's disease, which are associated with increased risk. The studies also discuss the genetic architecture of gene expression in peripheral blood and the interaction of amyloid-beta with apolipoprotein E4, which is a key factor in Alzheimer's pathogenesis.",0.8488788604736328,0.7655633687973022,0.6072630882263184
1000,20,5,What genomic findings support the involvement of microglial function in Alzheimer’s disease?,"The provided citations support the involvement of microglial function in Alzheimer's disease. A genome-wide meta-analysis identified new loci and functional pathways influencing Alzheimer's disease risk, while meta-analyses identified 29 risk loci and 215 potential causative genes. Associated genes are strongly expressed in immune-related tissues and cell types, spleen, liver, and microglia. Gene-set analyses indicate biological mechanisms involved in lipid-related processes and degradation.",0.7813864350318909,0.836327314376831,0.5450038909912109
